DCB29 is a selective inhibitor of the BPTF bromodomain, with an IC50 value of 13.2 µM. DCB29 can be used for the study of the treatment of BPTF-related diseases (such as bladder cancer, colorectal cancer, melanoma, leukemia, and other cancers)[1].
Molekulargewicht:
321.11
CAS Nummer:
[723245-31-6]
Formel:
C10H12INO3
Target-Kategorie:
Epigenetic Reader Domain
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
